The Salmonella Type III Effector SspH2 Specifically Exploits the NLR Co-chaperone Activity of SGT1 to Subvert Immunity-Reference-Cited by-同舟云学术

The Salmonella Type III Effector SspH2 Specifically Exploits the NLR Co-chaperone Activity of SGT1 to Subvert Immunity

Published:2013-07-25 Issue:7 Volume:9 Page:e1003518
ISSN:1553-7374
Container-title:PLoS Pathogens
language:en
Short-container-title:PLoS Pathog

Author:

Bhavsar Amit P.,Brown Nat F.,Stoepel Jan,Wiermer Marcel,Martin Dale D. O.,Hsu Karolynn J.,Imami Koshi,Ross Colin J.,Hayden Michael R.,Foster Leonard J.,Li Xin,Hieter Phil,Finlay B. Brett

Publisher

Public Library of Science (PLoS)

Subject

Virology,Genetics,Molecular Biology,Immunology,Microbiology,Parasitology

Reference38 articles.

1. Assembly and function of type III secretory systems;GR Cornelis;Annu Rev Microbiol,2000

2. Manipulation of host-cell pathways by bacterial pathogens;AP Bhavsar;Nature,2007

3. Cellular microbiology of intracellular Salmonella enterica: functions of the type III secretion system encoded by Salmonella pathogenicity island 2;V Kuhle;Cell Mol Life Sci,2004

4. Functions of the Salmonella pathogenicity island 2 (SPI-2) type III secretion system effectors;R Figueira;Microbiology,2012

5. A family of Salmonella virulence factors functions as a distinct class of autoregulated E3 ubiquitin ligases;CM Quezada;Proc Natl Acad Sci U S A,2009

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Salmonella infection impacts host proteome thermal stability;European Journal of Cell Biology;2024-12

2. The Salmonella Effector SspH2 Facilitates Spatially Selective Ubiquitination of NOD1 to Enhance Inflammatory Signaling;Biochemistry;2024-08-27

3. Engineered Ubiquitin Variants Mitigate Pathogenic Bacterial Ubiquitin Ligase Function;2024-05-01

4. Specificities and redundancies in the NEL family of bacterial E3 ubiquitin ligases of Salmonella enterica serovar Typhimurium;Frontiers in Immunology;2024-02-01

5. Survival strategies of intracellular bacterial pathogens;Molecular Medical Microbiology;2024